Qubit Pharmaceuticals honored to announce the arrival of renowned researcher Dr. Alberto Peruzzo as R&D Lead in Quantum Computing
Qubit Pharmaceuticals honored to announce the arrival of renowned researcher Dr. Alberto Peruzzo as R&D Lead in Quantum Computing
- Qubit Pharmaceuticals honored to announce the arrival of renowned researcher Dr. Alberto Peruzzo as R&D Lead in Quantum Computing
Paris (France), November 7, 2023 - Qubit Pharmaceuticals, a deeptech company specializing in drug discovery through simulation and molecular modeling accelerated by hybrid HPC and quantum computing, announces the arrival of Dr Alberto Peruzzo as Quantum Computing R&D Lead. - Alberto Peruzzo, 45, is a renowned researcher with a prestigious career in both academia and industry.
- He was later awarded a prestigious Royal Academy of Engineering Research Fellowship to contribute to the future of quantum computing.
- With Dr. Peruzzo on board, Qubit Pharmaceuticals is poised to leverage quantum computing to drive innovation in the pharmaceutical sector.